Check out our most popular compounded medications! Get Started
Bupivacaine HCL 1%/Diclofenac Sodium 8% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This formulation is designed for easy and precise application on the skin, allowing for targeted treatment or absorption of the active ingredients. The gel-like consistency ensures a smooth and comfortable application process.
The active ingredients, Bupivacaine HCL and Diclofenac Sodium, work together to provide relief from various disease states. Bupivacaine HCL is a local anesthetic that blocks nerve signal transmission, thereby reducing pain sensation. Diclofenac Sodium is a nonsteroidal anti-inflammatory drug (NSAID) that reduces inflammation and pain in the body.
It can also be used to manage post-surgical pain, providing targeted relief right where it's needed.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
This formulation combines Bupivacaine HCL 1% and Diclofenac Sodium 8% in a topical gel format. Bupivacaine HCL is a local anesthetic that works by blocking nerve impulses, thereby reducing pain sensation. Diclofenac Sodium is a nonsteroidal anti-inflammatory drug (NSAID) that reduces inflammation and pain by inhibiting the production of prostaglandins, substances in the body that cause inflammation and increase pain sensitivity.
The gel is a semisolid formulation that is dispensed through a pump mechanism. This design allows for easy and precise application on the skin, ensuring targeted treatment and optimal absorption of the active ingredients. The gel-like consistency also provides a soothing effect and allows for a more comfortable application compared to other dosage forms.
These include conditions like osteoarthritis, rheumatoid arthritis, and other musculoskeletal disorders. It can also be used for post-surgical pain management, sports injuries, and other conditions where localized pain relief is needed.
For patients, it's important to apply the gel as directed by your healthcare provider, usually to the affected area 3-4 times daily. Avoid contact with eyes and mucous membranes, and wash your hands thoroughly after application. If you experience any adverse reactions such as skin irritation, rash, or unusual symptoms, discontinue use and consult your healthcare provider immediately.
For prescribers, please consider the patient's overall health status, other medications, and potential drug interactions before prescribing this formulation. Monitor the patient's response to therapy and adjust the dosage as necessary. This formulation should not be used in patients with known hypersensitivity to Bupivacaine, Diclofenac, or any other component of the formulation.
If you have any questions or need further information about this formulation, please don't hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is always here to assist you.
Bupivacaine HCL 1%/Diclofenac Sodium 8% Topical Gel is a combination medication used to provide local anesthesia and pain relief. Bupivacaine HCL is a local anesthetic that works by blocking nerve signals in your body, while Diclofenac Sodium is a nonsteroidal anti-inflammatory drug (NSAID) that works by reducing substances in the body that cause pain and inflammation.
While this formulation is generally safe for most patients, it's important to be aware of potential drug interactions. Certain medications may interact with Bupivacaine HCL and Diclofenac Sodium, potentially altering their effectiveness or increasing the risk of adverse effects.
Medications that may interact with Bupivacaine HCL include other local anesthetics, certain antiarrhythmic drugs (such as amiodarone, quinidine), cimetidine, and certain beta blockers (such as atenolol). These drugs may increase the blood levels of Bupivacaine HCL, potentially leading to increased side effects.
Diclofenac Sodium may interact with anticoagulants (such as warfarin), antiplatelet drugs (such as clopidogrel), certain antidepressants (such as SSRIs/SNRIs), other NSAIDs (such as ibuprofen, naproxen), and certain high blood pressure medications (such as ACE inhibitors, ARBs). These interactions may increase the risk of serious gastrointestinal bleeding and may also affect how well Diclofenac Sodium works.
It's important to inform your healthcare provider about all the medications you're currently taking, including prescription drugs, over-the-counter medications, vitamins, and herbal supplements. This will help your healthcare provider to monitor for drug interactions and manage them appropriately.
While using this medication, avoid consuming alcohol as it may increase the risk of stomach bleeding. Also, avoid prolonged exposure to sunlight as Diclofenac Sodium can make your skin more sensitive to sunlight.
This formulation is intended for topical use only. It should not be ingested or applied to open wounds or damaged skin. If you experience any unusual symptoms or side effects, such as severe skin irritation, redness, swelling, or signs of an allergic reaction (such as rash, itching/swelling, severe dizziness, trouble breathing), seek immediate medical attention.
If you have any questions or concerns about this medication, its use, or potential interactions, please don't hesitate to reach out to us.
Bupivacaine HCL 1%/Diclofenac Sodium 8% Topical Gel is a unique formulation that combines the analgesic and anti-inflammatory properties of two active ingredients: Bupivacaine HCL and Diclofenac Sodium. This formulation is designed to provide targeted relief from pain and inflammation when applied topically to the skin.
Bupivacaine HCL is a local anesthetic that works by blocking nerve signals in your body. It numbs the skin and surrounding tissues, reducing the sensation of pain in the applied area.
Diclofenac Sodium, on the other hand, is a nonsteroidal anti-inflammatory drug (NSAID). It works by reducing substances in the body that cause pain and inflammation. When applied topically, Diclofenac Sodium can directly target the area of inflammation, providing relief without the systemic side effects often associated with oral NSAIDs.
The gel formulation allows for easy and precise application. It is dispensed through a pump mechanism, which ensures that the correct dose is applied each time. The gel-like consistency allows for the active ingredients to be absorbed through the skin directly into the affected area, providing targeted treatment.
This formulation is used to treat various disease states that involve pain and inflammation. These may include conditions like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and other musculoskeletal conditions. It can also be used to manage pain from surgical procedures or injuries.
It's important to note that while this formulation can provide significant relief from pain and inflammation, it does not cure the underlying disease or condition. It should be used as part of a comprehensive treatment plan, under the guidance of a healthcare provider.
If you have any questions about Bupivacaine HCL 1%/Diclofenac Sodium 8% Topical Gel, or if you would like more information about how it works, please don't hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is always here to help.
This Bupivacaine HCL 1%/Diclofenac Sodium 8% Topical Gel formulation is primarily used for its analgesic and anti-inflammatory properties. While it is most often used to manage certain types of pain, including but not limited to neuropathic pain, osteoarthritis pain, musculoskeletal disorders, sport-related injuries, and post-surgical pain, the medication's properties can make it useful in other areas as well.
For instance, this topical gel may be applied to the skin for the relief of skin conditions associated with inflammation and pain. These could include certain types of dermatitis or psoriasis, where inflammation is a significant concern. Also, in the clinical setting, this formulation may be used as part of multidrug treatment strategies, as adjuvant therapy to other pain management practices, or when oral administration of medication is not feasible or is contraindicated. In some cases, this topical gel may also be used to help manage symptoms in certain inflammatory conditions of the rectum or anus, such as hemorrhoids, but this should always be under the advice and supervision of a healthcare professional.
It's important to note that use of this medication should always be directed by a healthcare provider, as each patient’s symptoms, medical history, and overall health status may dictate different uses and doses. The formulation may also cause side effects such as skin irritation, and long-term use may increase the risk of systemic side effects. The medication should only be used on intact skin, and patients should be advised to avoid contact with the eyes and mucous membranes.
Remember that this information is intended as a guide, not as a comprehensive resource. For specific inquiries, customized formulations, or personal recommendations on how this medication can benefit a specific condition, please do not hesitate to reach out. We’re here to provide accurate, professional advice curated for each patient’s unique needs.
This is a compounded formulation which comprises 1% Bupivacaine HCL and 8% Diclofenac Sodium. It's a semisolid gel designed to deliver active ingredients directly to the targeted area via application on the skin.
This formulation is dispensed through a pump mechanism. It facilitates easy and precise application of the formulation on the skin.
The topical gel is designed in a gel-like consistency which is easily absorbed into the skin to deliver the active ingredients to the targeted treatment area.
The gel should be applied directly to the skin over the targeted treatment area. The pump mechanism assists in precise application, ensuring the appropriate amount of medication is dispensed.
Patients who require targeted treatment with the active ingredients Bupivacaine HCL and Diclofenac Sodium may benefit from this formulation. Specifically, it is often utilized for pain and inflammation management.
The active ingredients in this formulation are Bupivacaine HCL at a 1% concentration and Diclofenac Sodium at an 8% concentration. These compounds work together to treat the targeted area.
Generally, it is suitable for most skin types. However, if you have skin allergies or conditions, you should consult your healthcare provider before starting use to ensure it is safe for your individual circumstance.
This is a prescription medication. It is important to use it as directed by your healthcare provider and not to share it with others, to ensure safe and appropriate use.
As with all medications, it is important to discuss potential interactions with your healthcare provider. Some other drugs could potentially interact with the active ingredients in this formulation.
If you experience any side effects or adverse reactions, you should stop using the formulation and contact your healthcare provider immediately. They can advise you on next steps and possible courses of action.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
